Translational Andrology And Urology

SCI SCIE

国际简称：TRANSL ANDROL UROL 参考译名：转化男科和泌尿科

主要研究方向：Medicine-Urology 非预警期刊

《转化男科和泌尿科》(Translational Andrology And Urology)是一本由AME Publishing Company出版的以Medicine-Urology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q3 JCR分区
321 年发文量
1.9 IF影响因子
未开放 是否OA
2012 创刊年份
6 issues/year 出版周期
English 出版语言

ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.

[ 查看全部 ]

投稿咨询加急咨询

Translational Andrology And Urology期刊信息

ISSN：2223-4683
出版语言：English
是否OA：未开放
E-ISSN：2223-4691
出版地区：China
是否预警：否
出版商：AME Publishing Company
出版周期：6 issues/year
创刊时间：2012
开源占比：0.9946
Gold OA文章占比：100.00%
OA被引用占比：0.6666...
出版国人文章占比：0.19
出版撤稿占比：
研究类文章占比：86.60%

Translational Andrology And Urology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.4

0.505

0.655

学科类别	分区	排名	百分位
大类：Medicine 小类：Urology	Q3	63 / 123	49%
大类：Medicine 小类：Reproductive Medicine	Q3	56 / 99	43%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Translational Andrology And Urology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	ANDROLOGY 男科学 UROLOGY & NEPHROLOGY 泌尿学与肾脏学	4区 4区

Translational Andrology And Urology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ANDROLOGY	SCIE	Q3	6 / 8	31.3
学科：UROLOGY & NEPHROLOGY	SCIE	Q3	81 / 134	39.9
学科：ANDROLOGY	SCIE	Q4	7 / 8	18.75
学科：UROLOGY & NEPHROLOGY	SCIE	Q2	66 / 134	51.12

Translational Andrology And Urology历年数据统计

影响因子

中科院分区

Translational Andrology And Urology中国学者发文选摘

1、Global research landscape and technological breakthroughs in post-prostatectomy urinary incontinence management: a bibliometric review and visualized stud
Author: Zhang, Xu; Zhang, Ju; Fu, Tong; Shao, Jianfeng; Chen, Yuqing; Duan, Xuchu

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-1-908
2、Homozygous ARMC12 variant causes multiple morphological abnormalities of the sperm flagell
Author: Xue, Yu; Yang, Jie; Qiao, Sen; Shi, Shengjia

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-aw-849
3、Comparative efficacy and safety of insulin pump versus multiple daily injections in early-stage diabetic nephropathy: a systematic review and meta-analysi
Author: Xu, Man; Huang, Jin-Jing; Qin, Xiao-Hua; Zhu, Shu-Ying

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-aw-823
4、Combined anatomical parameters predict benign prostatic hyperplasia-related lower urinary tract symptom severity: a volume-stratified stud
Author: Wang, Yao-Xia; Huang, Yu-Hua; Li, Yi; Liang, Yin-Ying; Zhang, Ling-Yan; Zhuo, Yu-Min; Chen, Zheng; Huang, Jun

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-1-919
5、From symptomatic relief to restorative medicine: a comprehensive review of diabetic erectile dysfunctio
Author: Wang, Huan; Li, Chuangui; Zhang, Tianzi; Li, Siqi

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-1-945
6、Radiomics and deep learning fusion model based on multiphasic CT for predicting HER2 expression status in bladder urothelial carcinoma: a multicenter stud
Author: Pan, Wenbang; Yang, Liu; Yang, Lin; Gu, Chaohui; Lv, Qiang; Zhang, Yingyi; Li, Mingyue

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-1-899
7、Real-world efficacy and safety of disitamab vedotin (RC48) plus PD-1 inhibitors in advanced urothelial carcinoma: a single-center retrospective stud
Author: Lv, Ya-Hui; Cui, Xiao-Ran; Yu, Lu; Li, Tao; Liu, Chang; Liu, Mei-Cen; Ji, Yin-Min; Xiao, Shu-Yan; Hu, Yi; Zhang, Tong; Liu, Zhe-Feng

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-1-942
8、Construction of a survival model for predicting biochemical recurrence of prostate cancer based on propionate metabolism-related gene
Author: Lu, Baosai; Niu, Yalin; Liu, Xi; Zhao, Chenming; Yin, Yuewei

Journal: TRANSLATIONAL ANDROLOGY AND UROLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tau-2025-aw-811